Clinical Trial Update: Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is recruiting to evaluate levothyroxine as an adjuvant to a hypocaloric diet for obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Obesity | Phase 3 | Status: RECRUITING